These findings indicated that rPR8-CCL19 could induce the apoptosis of CRC cells, whose oncolytic capability remained consistent across different cell lines, maintaining its therapeutic efficacy against different types of CRC. The gene discussed is CCL19; the disease is colorectal carcinoma.